{{Rsnum
|rsid=17556665
|Gene=SPON1
|Chromosome=11
|position=14076935
|Orientation=plus
|GMAF=0.06107
|Gene_s=SPON1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 76.1 | 21.2 | 2.7
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 98.0 | 2.0 | 0.0
| ASW | 94.7 | 5.3 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 93.1 | 6.9 | 0.0
| LWK | 98.2 | 1.8 | 0.0
| MEX | 82.5 | 15.8 | 1.8
| MKK | 95.5 | 4.5 | 0.0
| TSI | 71.6 | 25.5 | 2.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22228203
|Trait=None
|Title=A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network.
|RiskAllele=
|Pval=0.000001
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}